To investigate the feasibility of the Zucker fatty (ZF) rat as a model for research in to obesity-associated erectile dysfunction (OAED) and to determine the effect of low-intensity extracorporeal shockwave therapy (Li-ESWT) on penile tissue and function in these rats.
Objectives
To investigate the feasibility of the Zucker fatty (ZF) rat as a model for research in to obesity-associated erectile dysfunction (OAED) and to determine the effect of low-intensity extracorporeal shockwave therapy (Li-ESWT) on penile tissue and function in these rats.
Materials and methods
Eight new-born male Zucker lean (ZL group) rats (ZUCLepr fa 186) and 16 new-born male ZF rats (ZUC-Lepr fa 185) were injected with 5-ethynyl-2'-deoxyuridine (EdU) at birth to identify and monitor endogenous stem cells. Insulin tolerance testing was performed at 10 weeks of age. Beginning at 12 weeks of age, eight ZF rats were kept as controls, and the remaining eight ZF rats were treated with Li-ESWT (0.02 mJ/mm 2 , 3 Hz, 500 pulses; ZF + SW group) twice a week for 4 weeks. Following a 1-week washout period, erectile function was evaluated by measuring intracavernosal pressure (ICP) and mean arterial pressure (MAP). Penile tissues were then harvested for histological study to assess smooth muscle/collagen content and endothelium content in the corpora cavernosum. LipidTOX TM staining was used to evaluate lipid accumulation. EdU, as a marker of cell activation, and phosphorylated histone 3 (H3P), as a marker of cell mitosis, were also assessed.
Results
The ICP/MAP indicated that erectile function was severely impaired in the ZF group as compared with the ZL group. In the ZF + SW group, erectile function was significantly improved (P < 0.05). Muscle atrophy was seen in the ZF group, while Li-ESWT increased the muscle content in ZF + SW group. Moreover, the penile endothelium was damaged in the ZF group, and Li-ESWT enhanced the regeneration of endothelial cells (P < 0.01) in the ZF + SW group. Lipid accumulation was seen in the penile tissue of ZF rats. Li-ESWT significantly reduced both the amount and the distribution pattern of LipidTOX, suggesting decreased overall lipid infiltration. Furthermore, Li-ESWT increased EdUpositive cells and markedly enhanced the phosphorylation level of H3P at Ser-10 in the ZF + SW group. Most H3P-positive cells were located within smooth muscle cells, with some located in the endothelium suggesting that these tissues are the reservoirs of penile stem/progenitor cells.
Conclusion
ZF rats can serve as an animal model in which to study OAED. This study reveals that obesity impairs erectile function by causing smooth muscle atrophy, endothelial dysfunction, and lipid accumulation in the corpus cavernosum. Li-ESWT restored penile haemodynamic parameters in the ZF rats by restoring smooth muscle and endothelium content and reducing lipid accumulation. The underlying mechanism of Li-ESWT appears to be activation of stem/progenitor cells, which prompts cellular proliferation and accelerates penile tissue regeneration. Our findings are of interest, not just as a validation of this emerging treatment for erectile dysfunction, but also as a novel and potentially significant method to modulate endogenous stem/progenitor cells in other disease processes.
Introduction
The number of obese people, in both developed and developing countries, has increased continuously during the past 30 years [1] . In the USA alone, >78 million people are obese. Obese men in particular are at high risk of developing erectile dysfunction (ED) [2, 3] . The prevalence of obesity in men reporting symptoms of ED may be as high as 79% [4] , although vascular risk factors commonly associated with obesity may also play a crucial role. Patients with obesityassociated ED (OAED) often have a poor response to the first-line therapy [5] , phosphodiesterase type 5 (PDE5) inhibitors, and therefore novel therapeutic modalities for OAED are in high demand.
Although it is clear that obesity and ED are closely linked, little is known about the mechanisms of OAED. Previous studies have used animal models of diet-induced obesity to investigate OAED [6, 7] . This is not an ideal animal model, as most of the diet-induced animals develop diabetes mellitus, which itself may impair erectile function. Zucker fatty (ZF) rats, which feature a leptin receptor gene mutation, develop glucose intolerance without diabetes mellitus and are used to study genetic obesity, insulin resistance, glucose intolerance, and metabolic syndrome. Therefore, the ZF rat is conceivably a superior animal model for the study of OAED. Several studies have shown ED in these rats, although the underlying mechanisms are far from well understood [8, 9] .
Low-intensity extracorporeal shockwave therapy (Li-ESWT) has been used to treat musculoskeletal disorders for decades [10] . Previous studies have shown that Li-ESWT has been expanded to address neurovascular ED [11] . Li-ESWT has the ability to mobilise stem cells to the site of injury, to promote nerve regeneration, and to reverse muscle content reduction. Furthermore, our recent study indicates that Li-ESWT activates penile endogenous stem cells in normal rats [12] . To the best of our knowledge, the utility of Li-ESWT for potentiation of erectile function in an animal model of obesity has not yet been explored.
In the present study, we treated ZF rats with Li-ESWT. After treatment, the rats underwent functional testing of erectile haemodynamics, as well as histological and molecular assessment of corpus cavernosum tissues. Our goals were to elucidate how obesity affects the structure and function of the penis in a rat model of genetic obesity and to investigate the feasibility and underlying mechanisms of the therapeutic effect of Li-ESWT in OAED.
Material and Methods

Animals
Experiments were approved by the Institutional Animal Care and Use Committee at the University of California, San Francisco, USA. Eight new-born male Zucker lean (ZL group) rats (ZUC-Lepr fa 186) and 16 Zucker fatty (ZF) rats (ZUCLepr fa 185) were used in this study. To track putative endogenous stem cells, each pup received an intraperitoneal (i.p.) injection of 5-ethynyl-2'-deoxyuridine (EdU, 150 mg/kg; Invitrogen, Carlsbad, CA, USA) at birth, as previously described [13] . Body weight was monitored every 2 weeks. At the age of 10 weeks, all rats underwent insulin tolerance testing. At 12 weeks, the remaining eight ZF rats were treated with Li-ESWT (0.02 mJ/mm 2 , 3 Hz, 500 pulses; ZF + SW group) twice a week for 4 weeks. The rest of the ZF rats were used as the ZF control (ZF group). Application of Li-ESWT was performed using a compact defocused electromagnetic unit (LiteMed Inc., Taipei, Taiwan). Following a 1-week washout period, erectile function was evaluated by measuring intracavernosal pressure (ICP) and mean arterial pressure (MAP). After surgery, the rats were humanely killed, and penile tissues were harvested for histological study.
Intraperitoneal insulin tolerance test
All rats were fasted for 6 h with free access to drinking water. Basal blood glucose levels were measured before insulin injection. Fast-acting insulin (Sigma-Aldrich, St. Louis, MO, USA) was given at a dose of 0.5 IU/kg by i.p. injection. Blood was taken by tail puncture at 30, 60, 90, and 120 min after insulin administration and a blood glucose meter (ACCU-CHEK Active; Roche Diagnostics, Indianapolis, IN, USA) was used to measure blood glucose.
Erectile function evaluation
The ICP was measured as previously described [14] . Briefly, under anaesthesia (ketamine and midazolam, 100 mg/kg and 5 mg/kg, respectively), the major pelvic ganglion and cavernous nerve were exposed via a midline laparotomy. A 25-G butterfly needle was inserted into the left penile crus to monitor ICP. A polyethylene-50 tube filled with heparinised saline (200 IU/mL) was cannulated into the left common carotid artery and connected to a pressure transducer (Utah Medical Products, Midvale, UT, USA) to continuously monitor MAP. Erectile response was elicited by electrical stimulation using a bipolar electrode hooked to the cavernous nerve. Stimulation parameters were 1.5 mA, 20 Hz, pulse width 0.2 ms, and duration 50 s. The maximum increase of ICP for three stimuli on each side for each rat was used for statistical analysis. The ratios between increase ICP and MAP (ICP/MAP) were calculated to normalise for variations in systemic blood pressure. Total ICP was determined by the area under the curve (AUC) during stimulation.
Immunofluorescence and lipid droplet staining
Cryosections of penile tissue samples were prepared according to a previously described protocol [15] . Tissue sections were 134 © 2018 The Authors BJU International © 2018 BJU International incubated with primary antibodies, including anti-a-smooth muscle actin (a-SMA) antibody (1:1000; Sigma-Aldrich), mouse anti-rat endothelial cell antigen 1 (RECA-1) antibody clone HIS52 (1:500; Bio-Rad, Hercules, CA, USA) and antiphospho-histone H3 (Ser10) antibody (H3P, 1:100; Merck Millipore, Billerica, MA, USA). Smooth muscle was stained by Alexa-488-conjugated phalloidin (1:500; Invitrogen). Sections were assessed for EdU labelling using the Click-iT reaction cocktail (Invitrogen), which contained Alexa Fluor 594 (1:500), for 30 min at room temperature, followed by staining with 4', 6-diamidino-2-phenylindole (DAPI, for nuclear staining, 1 lg/mL, Invitrogen).
For identifying the location of lipid deposition in the penile tissue, LipidTOX TM (Invitrogen) and phalloidin double staining was used as previously described [2] . Following phalloidin staining, LipidTOX neutral lipid stain (1:200; Invitrogen) was applied to the slides at room temperature for 30 min. Nuclear staining was performed by incubation with DAPI.
Masson's trichrome staining
Penile tissue sections were prepared as above. Masson's trichrome staining was carried out according to the standard protocol. Semi-quantitative analysis was performed to evaluate intensity using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD, USA).
Image analysis and quantification
For image analysis, four fields per tissue per rat in each treatment group were randomly selected, photographed, and recorded using a Retiga Q Image digital still camera and ACT-1 software (Nikon Instruments Inc., Melville, NY, USA). To evaluate penile lipid accumulation, five fields in the sections were photographed at 9200. For quantifying lipid accumulation, the LipidTOX-positive area (in red) was measured and expressed as a percentage of the total area.
Statistical analysis
Results were analysed using GraphPad Prism, version 6.02 (GraphPad Software, San Diego, CA, USA) and expressed as means AE standard deviations (SDs). Statistical analyses were performed using one-way ANOVA followed by the Tukey's multiple comparisons test. Differences amongst groups were considered statistically significant at P < 0.05.
Results
Metabolic variables
The body weight of the ZF rats was higher than that of the ZL rats starting at the age of 6 weeks (P < 0.05, Fig. S1 ). During the insulin tolerance test, the initial blood glucose was higher in the ZF rats compared with the ZL rats (P < 0.05). The blood glucose levels dropped sharply in the ZL rats after insulin administration but declined gently and even rebounded at 60 min in the ZF rats (Fig. 1A) .
At 12 weeks, ZF rats had a higher body weight compared to ZL rats (P < 0.05). At both the week 12 randomisation and after the 4-week treatment, ZF and ZF + SW groups did not differ with respect to body weight (Fig. 1B , P = 0.18 and P = 0.54, respectively. Table S1 ).
Li-ESWT ameliorates impaired erectile function in ZF rats
As illustrated in Figure 2 
Li-ESWT improves smooth muscle content and the ratio of smooth muscle to collagen in the corpus cavernosum
As evidenced by the significant decrease in smooth muscle content in penile tissue of ZF rats as compared to ZL rats, obesity provoked cavernous smooth muscle atrophy. After Li-ESWT, the ZF + SW group showed significant regeneration of smooth muscle content. In addition, as shown in Figure 3 , Li-ESWT reduced cavernous fibrosis in ZF + SW rats. In the ZL group, the mean (SD) smooth muscle/collagen ratio was 0.220 (0.035), whilst the ratio in penile tissue from ZF rats was strikingly decreased at 0.140 (0.017). Li-ESWT almost fully preserved the ratio, at 0.217(0.033) in the ZF + SW group.
Li-ESWT reverses endothelium damage in ZF rats
As shown in Figure 4 , RECA-1 (a specific marker for endothelium in rats) markedly decreased in the ZF group as compared to that of the ZL group. Endothelial cells form a complete lining of the sinusoids within the erectile tissue. Disruption of the integrity of the endothelial monolayer was seen in the ZF group but not the ZL group. Li-ESWT preserved the integrity of the sinusoidal lining in the ZF + SW group. had a higher percentage of LipidTOX-positive area in the penile tissue, at a mean (SD) of 4.85 (0.64) vs 25.62 (2.48)%, P < 0.05). This is one possible mechanism to account for OAED. Few lipid droplets were seen in the corpus cavernosum of the ZL rats. Figure 5 shows that lipid droplets infiltrated the cavernous sinusoids in the ZF group but that Li-ESWT treatment reduced the total amount of lipid droplets in the ZF + SW group's cavernous tissue to a mean (SD) percentage of LipidTOX-positive area of 6.99 (1.38).
Li-ESWT activates EdU-positive (EdU+) progenitor/ stem cells in the corpus cavernosum
Progenitor cells or cells with stem properties are characterised by the ability to retain nucleotide analogues, such as 5-bromo-2'-deoxyuridine (BrdU) or EdU, for a prolonged period of time. Therefore, we examined EdU+ cells in the penile cavernous tissue to identify and monitor penile progenitor cells. The total number of EdU+ cells in the ZF group showed a conspicuous decrease (P < 0.05) in comparison to the ZL group. Moreover, after Li-ESWT treatment, the total number of EdU+ cells increased dramatically in the ZF + SW group (Fig. 6 ).
Li-ESWT promotes endogenous stem/progenitor cells proliferation in ZF rats
To test whether the increase in EdU+ cells was the result of resident stem cell proliferation, we assessed the number of cells staining positive for H3P, a nuclear protein indicative of cell proliferation. We noted no significant difference between the ZL and ZF groups, but there was an obvious increase in the *P < 0.05; **0.01 < P < 0.05; ***P < 0.01 compared with the ZL group; # P < 0.05; ### P < 0.01 compared with the ZF group.
© 2018 The Authors BJU International © 2018 BJU International 137 number of H3P-positive (H3P+) cells in the ZF + SW group as compared to the ZL and ZF control groups (Fig. 7A and B) . Activated H3P+ cells were tracked by staining with cell markers for differentiated cells. Dividing cells (H3P+) co-expressing ether a-SMA or RECA-1 were found in the cavernosal sinusoids and sinusoidal endothelial lining, respectively (Fig. 7C) .
Discussion
In the present study, we used a genetic obesity rat model to show that obesity alone significantly impairs erectile function by inducing penile smooth muscle atrophy, endothelial dysfunction, and lipid accumulation. Li-ESWT ameliorated ED in this rat model by activating penile endogenous stem cells and stimulating these cells to Obesity is associated with cardiovascular disease, hypertension, type 2 diabetes mellitus, hyperlipidaemia, and stroke. ED is regarded as a benchmark for the aforementioned diseases. However, the relationship between obesity and ED is controversial. In a retrospective study, Chung et al. [16] investigated erectile capacity in men with ED according to their relative weights and found that obesity in itself is not an underlying risk factor for ED. Several epidemiological studies suggest that obesity is independently related to the likelihood of ED [17] . In addition, treating obesity has been shown to restore erectile function in patients with OAED [4, 18] . In a recent study, Villalba et al. [8] used an insulin-resistant obese rat model to investigate penile artery changes and reported a reduction in the internal diameter of the penile artery, as well as a reduction in the vasodilatory response to PDE5 inhibitors. These findings indicate that obesity may influence male sexual function via direct and/or indirect mechanisms.
Our present study investigated the erectile function in obese rats in a pre-diabetic state and revealed that the fatty rats had impaired erectile function vs lean rats of the same age. Insulin resistance and lipid accumulation in the corpus cavernosum of the ZF rats resulted in penile smooth muscle atrophy and endothelial damage. These histological changes may account for the decreased sexual function in the ZF rats. From 6 weeks of age, the obesity phenotype in the ZF rats began to emerge. At 10 weeks of age, the ZF rats had marked insulin resistance. In obese subjects, adipose tissue secretes a number of cytokines, including leptin, tumour necrosis factor a (TNFa), interleukin 6, interleukin 1b, and plasminogen activator inhibitor-1 (PAI-1), in abnormal proportions [19] . These adipokines can trigger insulin resistance by modulating insulin signalling. c-JUN N-terminal kinase 1 (JNK1) is a protein kinase of the p38 mitogen-activated protein kinase (MAPK) family that is activated by many inflammatory stimuli including TNFa and interleukin 6 [20] . Activation of JNK1 leads to serine phosphorylation of insulin receptor substrate 1 (IRS-1), which induces insulin resistance. In addition, free fatty acids (FFAs) have been proposed to have an important role in the pathogenesis of obesity-related insulin resistance [21] . Plasma FFAs are commonly elevated in obese individuals due to the expansion in fat mass. FFAs serve as signalling molecules that activate protein kinase C, which can also result in phosphorylation of IRS-1. Furthermore, increases in FFAs promote fatty acid oxidation and storage and inhibit glucose oxidation, leading to further deleterious effects on insulin sensitivity [22] .
As evidenced by significant LipidTOX staining in the penile tissues of ZF rats in the present study, obesity-associated increases in FFAs and other lipids result in the storage of ectopic fat as lipid droplets in penile tissues. Accumulation of intramyocellular lipids is associated with deterioration of insulin sensitivity. In the present study, the majority of lipids in the ZF rat penis were extramyocellular lipids, possibly contributing to an impairment of veno-occlusion needed for erection [23] . Collectively, chronic systemic inflammation and elevated FFAs initiate insulin resistance as well as lipid accumulation in obesity, which results in cavernosal smooth muscle atrophy, endothelial dysfunction, and significantly decreases erectile function in ZF rats.
Li-ESWT has recently gained favour in the treatment of ED and may modify the underlying pathophysiology of ED [11, 24, 25] . In 2013, our group first reported the application of Li-ESWT in a diabetic ED rat model. Since then, several researchers from different groups have investigated the effectiveness of Li-ESWT in various pathological subtypes of ED [11, 25, 26] . In several clinical trials, Li-ESWT treatment achieved promising results, with improvements in cavernosal haemodynamics and the potential to enable penile rehabilitation without drug therapy [27, 28] . In these studies, researchers suggested that Li-ESWT ameliorated ED via restoring endothelial and smooth muscle content, promoting angiogenesis. However, the mechanisms underlying the penile regeneration were not elucidated. To address how Li-ESWT restores the cavernosal architecture, we used EdU to track penile endogenous stem/progenitor cells in the present study. Consistent with previous studies, Li-ESWT treatment restored erectile function and dramatically reversed the obesityassociated loss of smooth muscle and endothelium content. Moreover, as EdU was administrated immediately after birth, label-retaining cells (LRCs) are regarded as stem cells within the penile tissues. In obese individuals, the number of LRCs was significantly decreased, and with Li-ESWT treatment more LRCs were seen in the corpus cavernosum. Our recent study indicates that Li-ESWT activates endogenous penile stem cells in situ in both young and middle-aged Sprague-Dawley rats (red) and SMA (green) /RECA-1 (green), original magnification 9400. ***P < 0.01 compared to the ZL group; ### P < 0.01 compared to the ZF group.
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© 2018 The Authors BJU International © 2018 BJU International [12] . Our present data confirms that in the pathological state of obesity, Li-ESWT activates penile stem cells and promotes penile regeneration.
As we previously reported, there are various kinds of cells in the penis including terminally differentiated cells and stem/ progenitor cells [13] . Most cavernous smooth muscle cells and fibroblasts are terminally differentiated and cannot be activated to proliferate [12] . Histone 3 phosphorylation at Ser10 is a conserved event that occurs during mitosis and serves as a specific marker for mitotically active cells [29] . To elucidate the fate of activated endogenous stem cells, we performed H3P staining and staining for H3P+ cells co-expressing a-SMA or RECA-1. We found that the number of H3P+ cells was significantly higher in the ZF + SW penis after Li-ESWT treatment compared with the ZF group, indicating more stem/progenitor cells were activated to proliferation. More importantly, these cells committed to differentiate into functional cells, as evidenced by co-expression of a-SMA/RECA-1 and H3P in ZF rats treated with Li-ESWT. Taken together, Li-ESWT activated endogenous stem/progenitor cells in the penile tissues, and these activated cells underwent differentiation toward smooth muscle cells and endothelial cells, participating in penile tissue repair and regeneration.
Another possible mechanism for the recovery of erectile function in ZF + SW rats is the reduction of lipid accumulation caused by Li-ESWT. It has been shown that Li-ESWT can induce adenosine 5 0 -triphosphate (ATP) release [30] . FFAs serve as the major energy substrate in obesity [22] , thus we speculate that Li-ESWT might accelerate FFA consumption while releasing ATP. On the other hand, ATP has been identified as a trigger of the biological effects of shockwave treatment, which can activate MAPK and extracellular signal-regulated kinase 1/2 (ErK1/2) [31] . These signalling pathways are involved in cell proliferation and proper differentiation and could participate in penile tissue regeneration.
In summary, the present study shows that obesity is associated with ED and pathophysiological consequences including loss of smooth muscle, endothelial dysfunction, and lipid accumulation. Li-ESWT was able to partially but significantly restore erectile function and diminish these pathological changes in ZF rats. In addition, we showed that the beneficial effects of Li-ESWT appeared to involve enhanced endogenous stem/progenitor cell proliferation and differentiation. However, it should be cautioned that that present study has limitations and the findings require further validation, such as we did not have ZL rats treated with Li-ESWT in present study. Nevertheless, Li-ESWT is regarded as a safe method to treat musculoskeletal disorders and the dosage we used was much less than the dosage used for musculoskeletal disorders. Besides, our present study did not investigate the exact mechanisms of interaction between Li-EWST and tissue. In future studies, physicists, biologists, and clinicians should collaborate to delve deeper into the basis of Li-ESWT's biological effects. Moreover, because chronic systemic inflammation is thought to play a vital role in obesity-related diseases, future research addressing the effects of Li-ESWT on macrophages and inflammatory markers is warranted.
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